In an article published by Creditor Rights Coalition, Partner Philip Anker evaluates the Second Circuit’s recent decision in Purdue Pharma.
Excerpt: There are three lenses through which I view the Second Circuit’s recent decision in Purdue.
The first is one of policy – if I could amend the Bankruptcy Code, would it permit non-consensual, third-party releases?